BioAtla, Inc.
BCAB
$0.88
$0.055.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.71M | -59.52M | -61.88M | -69.78M | -81.82M |
| Total Depreciation and Amortization | 582.00K | 754.00K | 868.00K | 925.00K | 1.07M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.97M | 4.76M | 5.58M | 8.11M | 9.73M |
| Change in Net Operating Assets | 1.08M | 1.68M | -1.97M | -11.20M | -14.05M |
| Cash from Operations | -57.07M | -52.32M | -57.40M | -71.94M | -85.08M |
| Capital Expenditure | -- | -- | -- | -- | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -8.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.36M | 9.36M | 9.56M | 9.56M | 393.00K |
| Repurchase of Common Stock | -40.00K | -48.00K | -62.00K | -46.00K | -76.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -444.00K | -444.00K | -366.00K | -- | -- |
| Cash from Financing | 8.88M | 8.87M | 9.13M | 9.51M | 317.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.20M | -43.46M | -48.27M | -62.43M | -84.77M |